Regencell Bioscience (RGC) has had the highest return since January 1, 2026 by a large-cap US stock, returning 107.8%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 107.76% |
Sandisk (SNDK) | 54.45% |
Kratos Defense & Security Solutions (KTOS) | 48.53% |
Bloom Energy (BE) | 48.03% |
Revolution Medicines (RVMD) | 47.76% |
AeroVironment (AVAV) | 46.91% |
Karman (KRMN) | 43.1% |
Oklo (OKLO) | 42.33% |
Ast Spacemobile (ASTS) | 31.38% |
QXO (QXO) | 29.87% |
Amkor Technology (AMKR) | 27.38% |
Fortress Transp & Infra Inv (FTAI) | 24.09% |
Lam Research (LRCX) | 22.78% |
Builders FirstSource (BLDR) | 21.16% |
Intel (INTC) | 20.6% |
MP Materials (MP) | 20.44% |
Leonardo DRS, Inc Common Stock (DRS) | 20.13% |
Rocket Lab USA (RKLB) | 20.13% |
Entegris (ENTG) | 19.53% |
Rocket Companies (RKT) | 19.44% |
IREN (IREN) | 18% |
Schlumberger (SLB) | 17.68% |
Alcoa (AA) | 17.65% |
Nova (NVMI) | 17.28% |
Elbit Systems (ESLT) | 17.01% |
Large-cap stocks are treated as having a market cap of $10B+.
